America: Cloning
By Zogby,
Zogby
| 07. 02. 2001
| |
opposed
|
supportive
|
| Regarding cloning human beings, are you* |
90**
|
8
|
| - Democrats |
87
|
-
|
| - Republicans |
94
|
-
|
| |
yes
|
no
|
| Should the government closely regulate all cloning research in the US? |
52
|
-
|
| Should all cloning research be banned? |
40
|
-
|
* Also overwhelmingly opposed are 18-29 year-olds (82% opposed), 50-64 year-olds (89% opposed), high school graduates (92% opposed) and college graduates (89% opposed).
** 82% are strongly opposed
- Survey population: 1,209 adult Americans
- Date of survey: July 2 to July 15, 2001
- Conducted by: Zogby International
- Margin of error: 3%
- Source: "Zogby 'FutureWatch' Poll Reveals: Americans Strongly Oppose Human Cloning," Zogby International (November 26, 2001), http://www.zogby.com/news/readnews.cfm?ID=508
Related Articles
By Alistair Sponsel and Brian Sutton, Springer Nature | 10.05.2026
This essay, co-authored by a historian of science and an X-ray crystallographer, sheds new light on Rosalind Franklin’s Photograph 51. We refute the infamous claim that, unlike James Watson, Franklin failed to see the picture’s potential significance for interpreting the...
By Andrea Martani, BioNews | 10.05.2026
In July 2026, PET and ESHRE published a joint report containing the results of an international survey assessing public attitudes towards the use of embryos in the context of fertility treatment and research. Societal views on these matters are considered...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...